基于生物聚合物的瘤微环境响应纳米药物用于向癌症治疗
Abhishek Jha1, Manish Kumar1, Kanchan Bharti1
1Department of Pharmaceutical Engineering & Technology, Indian Institute of Technology (BHU), Varanasi, Uttar Pradesh, 221005, India.
Nanomedicine (London, England)
|March 6, 2024
概括
响应TME的纳米医学通过向瘤环境,提供精确的癌症治疗. 这种方法克服了传统纳米医学的局限性,提高了药物输送和疗效,同时最大限度地减少了副作用.
科学领域:
- 生物技术和纳米医学
- 瘤学和癌症治疗学 癌症治疗学
- 高分子科学和生物材料
背景情况:
- 纳米医学通过提高药物的溶解性,透性和向性输送来增强癌症治疗.
- 由于瘤微环境 (TME) 的复杂性,传统纳米医学面临着诸如目标外分布和有限的瘤内透等挑战.
- 瘤血管系统,密集的肌层和改变的TME阻碍了有效的纳米药物分发和治疗结果.
研究的目的:
- 审查对TME敏感生物聚合物的机制方面.
- 探索这些生物聚合物在开发先进的TME响应纳米医学中的应用.
- 突出TME响应性纳米医学在有效,安全和精确的癌症治疗中的潜力.
主要方法:
- 对TME响应生物聚合物的机械原理的审查.
- 对生物聚合物与特定的TME刺激 (如pH,酶,氧化还原潜力) 的相互作用进行分析.
- 检查纳米药物设计策略,利用这些响应性生物聚合物进行向药物输送.
主要成果:
- 响应TME的纳米医学利用特定的瘤微环境刺激来释放药物.
- 生物聚合物可以被设计为响应独特的TME条件,增强药物局部化.
- 这种有针对性的方法表明,有可能克服不响应的纳米载体的局限性.
结论:
- 对TME响应的纳米医药比传统疗法有了显著的进步.
- 使用TME特异性刺激可以更精确,更有效地将药物输送到癌症部位.
- 进一步开发对TME敏感的生物聚合物和纳米医学对改善癌症治疗结果具有很大的前景.
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
01:27Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
01:15Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K